Literature DB >> 16446718

Squamous cell carcinoma: from precursor lesions to high-risk variants.

Bruce R Smoller1.   

Abstract

Cutaneous squamous cell carcinoma is second only to basal cell carcinoma in its incidence within our population. It is among the most common types of neoplasm afflicting the human race. Most cases are related to exposure to sunlight. This initial portion of the chapter will focus upon the biologic progression that results in the ultimate development of fully formed squamous cell carcinoma. The latter portion will focus upon the histologic features of squamous cell carcinoma, which may be potential prognostic indicators. While pathologists currently provide clinicians with information about many histologic features that may affect the outcome for patients with melanoma, there is little impetus for similar behavior on the part of pathologists when diagnosing squamous cell carcinomas. This is largely due to the relatively low metastasis rate for these tumors compared with melanomas; however, it may be possible for pathologists to separate out those squamous cell carcinomas with a higher chance for recurrence and metastasis. This chapter will examine many of these histologic features and propose a rationale for including this information in pathology reports.

Entities:  

Mesh:

Year:  2006        PMID: 16446718     DOI: 10.1038/modpathol.3800509

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

1.  PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.

Authors:  Jennifer Freytag; Cynthia E Wilkins-Port; Craig E Higgins; Stephen P Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  J Invest Dermatol       Date:  2010-04-29       Impact factor: 8.551

Review 2.  Evolution of Premalignant Disease.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

3.  Spontaneous Development of Cutaneous Squamous Cell Carcinoma in Mice with Cell-specific Deletion of Inhibitor of κB Kinase 2.

Authors:  Kelly S Kirkley; Kelly D Walton; Colleen Duncan; Ronald B Tjalkens
Journal:  Comp Med       Date:  2017-10-01       Impact factor: 0.982

4.  PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Jennifer Freytag; Cynthia E Wilkins-Port; Craig E Higgins; J Andrew Carlson; Agnes Noel; Jean-Michel Foidart; Stephen P Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  J Oncol       Date:  2010-03-01       Impact factor: 4.375

5.  Susceptibility Loci-Associated Cutaneous Squamous Cell Carcinoma Invasiveness.

Authors:  Wei Wang; Eric Jorgenson; Alice S Whittemore; Maryam M Asgari
Journal:  J Invest Dermatol       Date:  2017-10-17       Impact factor: 8.551

6.  Value of CD10 Expression in Differentiating Cutaneous Basal from Squamous Cell Carcinomas and Basal Cell Carcinoma from Trichoepithelioma.

Authors:  Fatemeh Sari Aslani; Mojgan Akbarzadeh-Jahromi; Farideh Jowkar
Journal:  Iran J Med Sci       Date:  2013-06

7.  Squamous cell carcinoma in combination with a symbrachydactyly: initial management and long-term followup.

Authors:  Tomas Sanchez; Daniel Walder; Philipp Esenwein
Journal:  Case Rep Orthop       Date:  2014-06-15

8.  Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer.

Authors:  Jacek J Sznurkowski; Tomasz Milczek; Janusz Emerich
Journal:  Arch Gynecol Obstet       Date:  2012-12-22       Impact factor: 2.344

9.  TGF-beta1-Induced Expression of the Poor Prognosis SERPINE1/PAI-1 Gene Requires EGFR Signaling: A New Target for Anti-EGFR Therapy.

Authors:  Rohan Samarakoon; Craig E Higgins; Stephen P Higgins; Paul J Higgins
Journal:  J Oncol       Date:  2009-04-09       Impact factor: 4.375

10.  PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma.

Authors:  Cynthia E Wilkins-Port; Craig E Higgins; Jennifer Freytag; Stephen P Higgins; J Andrew Carlson; Paul J Higgins
Journal:  J Biomed Biotechnol       Date:  2007-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.